PML-RARA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,672 results for “PML-RARA”

Trials

View all 4662 →

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

151 participants · First posted Aug 4, 2011

Active, not recruiting

Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

202 participants · First posted Aug 18, 2017

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

77 participants · First posted Mar 17, 2015

Drugs

View all 635 →

RARI-049

Para-aspirin

RAPA-113

Organizations

View all 66 →

PMV Pharmaceuticals

United States

ANIRBAN PAL

India

BEAT AML, LLC

United States

News

View all 1309 →

Quetzal Therapeutics Initiates Phase III Trial of Oral Arsenic Trioxide QTX-2101 for Acute Promyelocytic Leukemia

Syros Pharma's Tamibarotene Fails in Phase III MDS Trial, Stock Plummets

First European Real-World Analysis Validates ImmunoWELL JCV Test for PML Risk Assessment in Multiple Sclerosis Patients

Page 1 of 668